The 'Bolar' Exemption and the Supply of Patented Active Pharmaceutical 
Ingredients to Generic Drug Producers - An Attempt to Interpret Article 10(6) 
of Directive 2004/27/EC

Straus, Joseph

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Contribution to Collected Edition

The 'Bolar' Exemption and the Supply of Patented Active Pharmaceutical Ingredients to Generic Drug Producers - An Attempt to Interpret Article 10(6) of Directive 2004/27/EC

MPS-Authors

/persons/resource/persons51252

Straus, Joseph
MPI for Innovation and Competition, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Straus, J. (2016). The 'Bolar' Exemption and the Supply of Patented Active Pharmaceutical Ingredients to Generic Drug Producers - An Attempt to Interpret Article 10(6) of Directive 2004/27/EC. In European Intellectual Property Law (pp. 165-179). Cheltenham, UK; Northampton, MA: Edward Elgar Publishing.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-DF9D-6

Abstract

There is no abstract available